HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke
In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA) class I molecules by killer immunoglobulin-like receptors (KIRs). To implement the knowledge about the immunological genetic background of acute ischemic str...
Saved in:
Published in | Journal of neuroinflammation Vol. 16; no. 1; pp. 88 - 15 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
17.04.2019
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA) class I molecules by killer immunoglobulin-like receptors (KIRs).
To implement the knowledge about the immunological genetic background of acute ischemic stroke susceptibility in relation to the frequency of the KIR genes and HLA alleles.
Subjects with acute ischemic stroke and subjects without stroke were genotyped for the presence of KIR genes and of the three major KIR ligand groups, HLA-C1, HLA-C2, and HLA-Bw4, both HLA-B and HLA-A loci.
Between November 2013 and February 2016, consecutive patients with acute ischemic stroke were recruited. As healthy controls, we enrolled subjects without acute ischemic stroke. Subjects with acute ischemic stroke in comparison with controls showed a higher frequency of 2DL3, 2DL5B, 2DS2, and 2DS4 KIR genes and a lower frequency of HLA-B-Bw4
alleles. Subjects without acute ischemic stroke showed a higher frequency of interaction between KIR 2DS2 and HLAC2. We also observed a higher frequency of 2DL3 and 2 DL4 KIR genes in subjects with atherosclerotic (LAAS) subtype. Multiple logistic regression analysis showed a protective effect towards stroke of HLA-B-Bw4
and interaction between KIR 2DL2 and HLAC1 and 2DS2-HLAC2 and a detrimental effect of 2DL2-HLA-C1_A interactions.
Our findings of a higher frequency of activating KIR genes seem to be consistent with findings previously reported patients with coronary syndrome. This higher frequency of "proinflammatory" genes in subjects with ischemic stroke could also explain the immunoinflammatory activation of the acute phase of stroke. |
---|---|
AbstractList | In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA) class I molecules by killer immunoglobulin-like receptors (KIRs).INTRODUCTIONIn humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA) class I molecules by killer immunoglobulin-like receptors (KIRs).To implement the knowledge about the immunological genetic background of acute ischemic stroke susceptibility in relation to the frequency of the KIR genes and HLA alleles.AIMSTo implement the knowledge about the immunological genetic background of acute ischemic stroke susceptibility in relation to the frequency of the KIR genes and HLA alleles.Subjects with acute ischemic stroke and subjects without stroke were genotyped for the presence of KIR genes and of the three major KIR ligand groups, HLA-C1, HLA-C2, and HLA-Bw4, both HLA-B and HLA-A loci.METHODSSubjects with acute ischemic stroke and subjects without stroke were genotyped for the presence of KIR genes and of the three major KIR ligand groups, HLA-C1, HLA-C2, and HLA-Bw4, both HLA-B and HLA-A loci.Between November 2013 and February 2016, consecutive patients with acute ischemic stroke were recruited. As healthy controls, we enrolled subjects without acute ischemic stroke. Subjects with acute ischemic stroke in comparison with controls showed a higher frequency of 2DL3, 2DL5B, 2DS2, and 2DS4 KIR genes and a lower frequency of HLA-B-Bw4I alleles. Subjects without acute ischemic stroke showed a higher frequency of interaction between KIR 2DS2 and HLAC2. We also observed a higher frequency of 2DL3 and 2 DL4 KIR genes in subjects with atherosclerotic (LAAS) subtype. Multiple logistic regression analysis showed a protective effect towards stroke of HLA-B-Bw4I and interaction between KIR 2DL2 and HLAC1 and 2DS2-HLAC2 and a detrimental effect of 2DL2-HLA-C1_A interactions.RESULTSBetween November 2013 and February 2016, consecutive patients with acute ischemic stroke were recruited. As healthy controls, we enrolled subjects without acute ischemic stroke. Subjects with acute ischemic stroke in comparison with controls showed a higher frequency of 2DL3, 2DL5B, 2DS2, and 2DS4 KIR genes and a lower frequency of HLA-B-Bw4I alleles. Subjects without acute ischemic stroke showed a higher frequency of interaction between KIR 2DS2 and HLAC2. We also observed a higher frequency of 2DL3 and 2 DL4 KIR genes in subjects with atherosclerotic (LAAS) subtype. Multiple logistic regression analysis showed a protective effect towards stroke of HLA-B-Bw4I and interaction between KIR 2DL2 and HLAC1 and 2DS2-HLAC2 and a detrimental effect of 2DL2-HLA-C1_A interactions.Our findings of a higher frequency of activating KIR genes seem to be consistent with findings previously reported patients with coronary syndrome. This higher frequency of "proinflammatory" genes in subjects with ischemic stroke could also explain the immunoinflammatory activation of the acute phase of stroke.CONCLUSIONOur findings of a higher frequency of activating KIR genes seem to be consistent with findings previously reported patients with coronary syndrome. This higher frequency of "proinflammatory" genes in subjects with ischemic stroke could also explain the immunoinflammatory activation of the acute phase of stroke. Introduction In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA) class I molecules by killer immunoglobulin-like receptors (KIRs). Aims To implement the knowledge about the immunological genetic background of acute ischemic stroke susceptibility in relation to the frequency of the KIR genes and HLA alleles. Methods Subjects with acute ischemic stroke and subjects without stroke were genotyped for the presence of KIR genes and of the three major KIR ligand groups, HLA-C1, HLA-C2, and HLA-Bw4, both HLA-B and HLA-A loci. Results Between November 2013 and February 2016, consecutive patients with acute ischemic stroke were recruited. As healthy controls, we enrolled subjects without acute ischemic stroke. Subjects with acute ischemic stroke in comparison with controls showed a higher frequency of 2DL3, 2DL5B, 2DS2, and 2DS4 KIR genes and a lower frequency of HLA-B-Bw4I alleles. Subjects without acute ischemic stroke showed a higher frequency of interaction between KIR 2DS2 and HLAC2. We also observed a higher frequency of 2DL3 and 2 DL4 KIR genes in subjects with atherosclerotic (LAAS) subtype. Multiple logistic regression analysis showed a protective effect towards stroke of HLA-B-Bw4I and interaction between KIR 2DL2 and HLAC1 and 2DS2-HLAC2 and a detrimental effect of 2DL2-HLA-C1_A interactions. Conclusion Our findings of a higher frequency of activating KIR genes seem to be consistent with findings previously reported patients with coronary syndrome. This higher frequency of “proinflammatory” genes in subjects with ischemic stroke could also explain the immunoinflammatory activation of the acute phase of stroke. In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA) class I molecules by killer immunoglobulin-like receptors (KIRs). To implement the knowledge about the immunological genetic background of acute ischemic stroke susceptibility in relation to the frequency of the KIR genes and HLA alleles. Subjects with acute ischemic stroke and subjects without stroke were genotyped for the presence of KIR genes and of the three major KIR ligand groups, HLA-C1, HLA-C2, and HLA-Bw4, both HLA-B and HLA-A loci. Between November 2013 and February 2016, consecutive patients with acute ischemic stroke were recruited. As healthy controls, we enrolled subjects without acute ischemic stroke. Subjects with acute ischemic stroke in comparison with controls showed a higher frequency of 2DL3, 2DL5B, 2DS2, and 2DS4 KIR genes and a lower frequency of HLA-B-Bw4 alleles. Subjects without acute ischemic stroke showed a higher frequency of interaction between KIR 2DS2 and HLAC2. We also observed a higher frequency of 2DL3 and 2 DL4 KIR genes in subjects with atherosclerotic (LAAS) subtype. Multiple logistic regression analysis showed a protective effect towards stroke of HLA-B-Bw4 and interaction between KIR 2DL2 and HLAC1 and 2DS2-HLAC2 and a detrimental effect of 2DL2-HLA-C1_A interactions. Our findings of a higher frequency of activating KIR genes seem to be consistent with findings previously reported patients with coronary syndrome. This higher frequency of "proinflammatory" genes in subjects with ischemic stroke could also explain the immunoinflammatory activation of the acute phase of stroke. In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA) class I molecules by killer immunoglobulin-like receptors (KIRs). To implement the knowledge about the immunological genetic background of acute ischemic stroke susceptibility in relation to the frequency of the KIR genes and HLA alleles. Subjects with acute ischemic stroke and subjects without stroke were genotyped for the presence of KIR genes and of the three major KIR ligand groups, HLA-C1, HLA-C2, and HLA-Bw4, both HLA-B and HLA-A loci. Between November 2013 and February 2016, consecutive patients with acute ischemic stroke were recruited. As healthy controls, we enrolled subjects without acute ischemic stroke. Subjects with acute ischemic stroke in comparison with controls showed a higher frequency of 2DL3, 2DL5B, 2DS2, and 2DS4 KIR genes and a lower frequency of HLA-B-Bw4.sup.I alleles. Subjects without acute ischemic stroke showed a higher frequency of interaction between KIR 2DS2 and HLAC2. We also observed a higher frequency of 2DL3 and 2 DL4 KIR genes in subjects with atherosclerotic (LAAS) subtype. Multiple logistic regression analysis showed a protective effect towards stroke of HLA-B-Bw4.sup.I and interaction between KIR 2DL2 and HLAC1 and 2DS2-HLAC2 and a detrimental effect of 2DL2-HLA-C1_A interactions. Our findings of a higher frequency of activating KIR genes seem to be consistent with findings previously reported patients with coronary syndrome. This higher frequency of "proinflammatory" genes in subjects with ischemic stroke could also explain the immunoinflammatory activation of the acute phase of stroke. Abstract Introduction In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA) class I molecules by killer immunoglobulin-like receptors (KIRs). Aims To implement the knowledge about the immunological genetic background of acute ischemic stroke susceptibility in relation to the frequency of the KIR genes and HLA alleles. Methods Subjects with acute ischemic stroke and subjects without stroke were genotyped for the presence of KIR genes and of the three major KIR ligand groups, HLA-C1, HLA-C2, and HLA-Bw4, both HLA-B and HLA-A loci. Results Between November 2013 and February 2016, consecutive patients with acute ischemic stroke were recruited. As healthy controls, we enrolled subjects without acute ischemic stroke. Subjects with acute ischemic stroke in comparison with controls showed a higher frequency of 2DL3, 2DL5B, 2DS2, and 2DS4 KIR genes and a lower frequency of HLA-B-Bw4I alleles. Subjects without acute ischemic stroke showed a higher frequency of interaction between KIR 2DS2 and HLAC2. We also observed a higher frequency of 2DL3 and 2 DL4 KIR genes in subjects with atherosclerotic (LAAS) subtype. Multiple logistic regression analysis showed a protective effect towards stroke of HLA-B-Bw4I and interaction between KIR 2DL2 and HLAC1 and 2DS2-HLAC2 and a detrimental effect of 2DL2-HLA-C1_A interactions. Conclusion Our findings of a higher frequency of activating KIR genes seem to be consistent with findings previously reported patients with coronary syndrome. This higher frequency of “proinflammatory” genes in subjects with ischemic stroke could also explain the immunoinflammatory activation of the acute phase of stroke. Introduction In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA) class I molecules by killer immunoglobulin-like receptors (KIRs). Aims To implement the knowledge about the immunological genetic background of acute ischemic stroke susceptibility in relation to the frequency of the KIR genes and HLA alleles. Methods Subjects with acute ischemic stroke and subjects without stroke were genotyped for the presence of KIR genes and of the three major KIR ligand groups, HLA-C1, HLA-C2, and HLA-Bw4, both HLA-B and HLA-A loci. Results Between November 2013 and February 2016, consecutive patients with acute ischemic stroke were recruited. As healthy controls, we enrolled subjects without acute ischemic stroke. Subjects with acute ischemic stroke in comparison with controls showed a higher frequency of 2DL3, 2DL5B, 2DS2, and 2DS4 KIR genes and a lower frequency of HLA-B-Bw4.sup.I alleles. Subjects without acute ischemic stroke showed a higher frequency of interaction between KIR 2DS2 and HLAC2. We also observed a higher frequency of 2DL3 and 2 DL4 KIR genes in subjects with atherosclerotic (LAAS) subtype. Multiple logistic regression analysis showed a protective effect towards stroke of HLA-B-Bw4.sup.I and interaction between KIR 2DL2 and HLAC1 and 2DS2-HLAC2 and a detrimental effect of 2DL2-HLA-C1_A interactions. Conclusion Our findings of a higher frequency of activating KIR genes seem to be consistent with findings previously reported patients with coronary syndrome. This higher frequency of "proinflammatory" genes in subjects with ischemic stroke could also explain the immunoinflammatory activation of the acute phase of stroke. Keywords: Stroke, Killer immunoglobulin-like receptors (KIRs), HLA |
ArticleNumber | 88 |
Audience | Academic |
Author | Di Bona, Danilo Tuttolomondo, Antonino Di Raimondo, Domenico Squatrito, Rosario Casuccio, Alessandra Pecoraro, Rosaria Aiello, Anna Pinto, Antonio Accardi, Giulia Corte, Vittoriano Della Clemente, Giuseppe Caruso, Calogero Arnao, Valentina Simonetta, Irene Maida, Carlo |
Author_xml | – sequence: 1 givenname: Antonino orcidid: 0000-0001-6440-7318 surname: Tuttolomondo fullname: Tuttolomondo, Antonino – sequence: 2 givenname: Domenico surname: Di Raimondo fullname: Di Raimondo, Domenico – sequence: 3 givenname: Rosaria surname: Pecoraro fullname: Pecoraro, Rosaria – sequence: 4 givenname: Alessandra surname: Casuccio fullname: Casuccio, Alessandra – sequence: 5 givenname: Danilo surname: Di Bona fullname: Di Bona, Danilo – sequence: 6 givenname: Anna surname: Aiello fullname: Aiello, Anna – sequence: 7 givenname: Giulia surname: Accardi fullname: Accardi, Giulia – sequence: 8 givenname: Valentina surname: Arnao fullname: Arnao, Valentina – sequence: 9 givenname: Giuseppe surname: Clemente fullname: Clemente, Giuseppe – sequence: 10 givenname: Vittoriano Della surname: Corte fullname: Corte, Vittoriano Della – sequence: 11 givenname: Carlo surname: Maida fullname: Maida, Carlo – sequence: 12 givenname: Irene surname: Simonetta fullname: Simonetta, Irene – sequence: 13 givenname: Calogero surname: Caruso fullname: Caruso, Calogero – sequence: 14 givenname: Rosario surname: Squatrito fullname: Squatrito, Rosario – sequence: 15 givenname: Antonio surname: Pinto fullname: Pinto, Antonio |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30995924$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ks1u1DAUhSNURNuBB2CDLLEpixT_JbE3SKMK6IiRkBCsLce5zngmsQcnKerb43Ra6FSgLBzZ53zJuT7n2YkPHrLsNcGXhIjy_UCorHiOicwJL2VePMvOSMVpTrHkJ4_eT7PzYdhizGhR0hfZKcNSFpLys8xdr5dI-wbtXNdBRAa6Drm-n3xou1BPnfN553aAIhjYjyGiiy-rb8M71IIP4-3e-RY5j_Z6dODHAf1y4wZpM42A3GA20DuDhjGGHbzMnlvdDfDqfl1kPz59_H51na-_fl5dLde5KUo85lZwYpuKWqGNBCmYrTiztsCGNVroUoIVGGgDFjCTDeG8glo0sxlTQxhbZKsDtwl6q_bR9TreqqCdutsIsVU6js50oKpaJpIwFjfAua2FIKysKK6KooDa4MT6cGDtp7qHxqSIUXdH0OMT7zaqDTeq5BWpEm2RXdwDYvg5wTCqPo0lzVh7CNOgKCWE0YrR-b_fPpFuwxR9GtWdimMhhfiranUK4LwN6btmhqplIRgRTCbYIrv8hyo9zXwhqUTWpf0jw5vHQf8kfChKElQHgYlhGCJYZdyYLj3MuV2nCFZzJdWhkipVUs2VVEVykifOB_j_Pb8Br-Xifg |
CitedBy_id | crossref_primary_10_1371_journal_pone_0240483 crossref_primary_10_3390_ijerph20021487 crossref_primary_10_3390_ijms21020606 crossref_primary_10_3390_ijms24108681 crossref_primary_10_1016_j_humgen_2022_201126 crossref_primary_10_1016_j_clnesp_2024_06_018 crossref_primary_10_3390_genes13060978 crossref_primary_10_1007_s11011_021_00792_7 crossref_primary_10_1038_s41392_021_00802_1 crossref_primary_10_31083_j_rcm2506199 crossref_primary_10_1007_s00251_023_01316_6 crossref_primary_10_1016_j_ejphar_2021_174360 crossref_primary_10_1097_MD_0000000000022465 crossref_primary_10_3390_ijms22094405 crossref_primary_10_3390_ph15101168 crossref_primary_10_2147_NDT_S265601 crossref_primary_10_2147_PGPM_S320483 crossref_primary_10_3390_idr16020029 crossref_primary_10_1038_s41598_024_83555_5 crossref_primary_10_3390_ijms25126297 crossref_primary_10_1080_01616412_2024_2340886 crossref_primary_10_1111_eci_13684 crossref_primary_10_3390_cells10092429 crossref_primary_10_3390_ijms25010061 crossref_primary_10_3390_ijms21186454 crossref_primary_10_3390_ijms24108619 crossref_primary_10_1007_s11011_021_00723_6 crossref_primary_10_2174_1381612826666200317142412 crossref_primary_10_1080_17501911_2024_2377947 crossref_primary_10_3390_ijms21207615 crossref_primary_10_3892_etm_2021_10919 crossref_primary_10_3389_fneur_2023_1207795 crossref_primary_10_3390_ijms23042306 crossref_primary_10_1016_j_neulet_2020_135616 crossref_primary_10_3390_diagnostics12061355 crossref_primary_10_1097_MD_0000000000026515 crossref_primary_10_1155_2022_1119611 crossref_primary_10_1186_s12915_022_01392_2 crossref_primary_10_1515_revneuro_2024_0128 crossref_primary_10_31083_j_jin_2021_01_228 crossref_primary_10_2174_138161282640201111114453 crossref_primary_10_1080_1744666X_2024_2392815 crossref_primary_10_3390_ijms21249372 crossref_primary_10_3390_genes13010048 crossref_primary_10_3390_ijms23052445 |
Cites_doi | 10.1073/pnas.95.7.3798 10.1084/jem.184.2.789 10.4049/jimmunol.0804224 10.1126/science.274.5295.2097 10.1016/j.jneuroim.2009.06.019 10.1177/039463200601900320 10.1161/ATVBAHA.113.302163 10.1161/01.CIR.100.21.2135 10.1161/01.STR.24.1.35 10.1161/01.CIR.101.25.2883 10.2174/138161212802481200 10.1097/00007890-199912150-00024 10.1161/01.ATV.19.7.1595 10.1161/STR.0b013e318296aeca 10.1212/01.WNL.0000142260.61443.7C 10.1016/j.jacc.2006.08.051 10.1073/pnas.0712229105 10.1126/science.1097670 10.1016/j.cmet.2010.12.008 10.1016/j.cyto.2012.02.012 10.1042/CS20080372 10.1097/01.hjh.0000431740.32696.cc 10.4049/jimmunol.1302843 10.1146/annurev.immunol.23.021704.115526 10.1084/jem.193.10.1159 10.1038/nature03847 10.1172/JCI119465 10.4049/jimmunol.159.8.3723 10.1385/NMM:7:3:229 10.1016/j.ijcard.2010.06.005 10.1016/S1074-7613(00)80394-5 10.1159/000102163 10.1093/infdis/jiu226 10.1161/hs0202.103399 10.1038/nrcardio.2009.55 10.1016/j.coi.2005.03.006 10.4049/jimmunol.155.9.4139 10.1097/MD.0000000000000813 10.1016/j.cell.2010.08.031 10.1073/pnas.94.19.10285 10.1016/j.smim.2008.06.003 10.1002/eji.200425932 10.1002/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6 10.1038/ni.2001 10.1161/circ.106.25.3143 10.1161/01.RES.0000082333.58263.58 10.1016/S0047-6374(97)00161-9 10.1016/S1357-4310(97)01077-0 |
ContentType | Journal Article |
Contributor | Caruso, Calogero Di Bona, Danilo Tuttolomondo, Antonino Di Raimondo, Domenico Pinto, Antonio |
Contributor_xml | – sequence: 1 givenname: Antonino surname: Tuttolomondo fullname: Tuttolomondo, Antonino – sequence: 2 givenname: Domenico surname: Di Raimondo fullname: Di Raimondo, Domenico – sequence: 3 givenname: Danilo surname: Di Bona fullname: Di Bona, Danilo – sequence: 4 givenname: Calogero surname: Caruso fullname: Caruso, Calogero – sequence: 5 givenname: Antonio surname: Pinto fullname: Pinto, Antonio |
Copyright | COPYRIGHT 2019 BioMed Central Ltd. 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s). 2019 |
Copyright_xml | – notice: COPYRIGHT 2019 BioMed Central Ltd. – notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s). 2019 |
CorporateAuthor | on behalf of KIRIIND (KIR Infectious and Inflammatory Diseases) Collaborative Group KIRIIND (KIR Infectious and Inflammatory Diseases) Collaborative Group |
CorporateAuthor_xml | – name: on behalf of KIRIIND (KIR Infectious and Inflammatory Diseases) Collaborative Group – name: KIRIIND (KIR Infectious and Inflammatory Diseases) Collaborative Group |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12974-019-1469-5 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts Neurosciences Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Proquest Medical Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1742-2094 |
EndPage | 15 |
ExternalDocumentID | oai_doaj_org_article_7b9e2d8cf0de44fb881367207555ebc0 PMC6471781 A583183932 30995924 10_1186_s12974_019_1469_5 |
Genre | Journal Article |
GeographicLocations | Italy |
GeographicLocations_xml | – name: Italy |
GroupedDBID | --- 0R~ 29L 2WC 53G 5GY 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS EJD ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ TR2 TUS UKHRP WOQ WOW XSB ~8M CGR CUY CVF ECM EIF NPM PMFND 3V. 7T5 7TK 7XB 8FK AZQEC DWQXO H94 K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c560t-f841fd72f8ac9e983f743ff50c3da8a69ef80e2defe039d1447eb8dc56002c133 |
IEDL.DBID | DOA |
ISSN | 1742-2094 |
IngestDate | Wed Aug 27 01:30:53 EDT 2025 Thu Aug 21 18:34:30 EDT 2025 Wed Jul 30 11:18:31 EDT 2025 Fri Jul 25 05:15:29 EDT 2025 Tue Jun 17 21:37:35 EDT 2025 Tue Jun 10 20:47:27 EDT 2025 Thu Apr 03 06:59:21 EDT 2025 Tue Jul 01 02:54:30 EDT 2025 Thu Apr 24 23:16:23 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | HLA Stroke Killer immunoglobulin-like receptors (KIRs) |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c560t-f841fd72f8ac9e983f743ff50c3da8a69ef80e2defe039d1447eb8dc56002c133 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-6440-7318 |
OpenAccessLink | https://doaj.org/article/7b9e2d8cf0de44fb881367207555ebc0 |
PMID | 30995924 |
PQID | 2211408988 |
PQPubID | 55345 |
PageCount | 15 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_7b9e2d8cf0de44fb881367207555ebc0 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6471781 proquest_miscellaneous_2211327323 proquest_journals_2211408988 gale_infotracmisc_A583183932 gale_infotracacademiconefile_A583183932 pubmed_primary_30995924 crossref_citationtrail_10_1186_s12974_019_1469_5 crossref_primary_10_1186_s12974_019_1469_5 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-04-17 |
PublicationDateYYYYMMDD | 2019-04-17 |
PublicationDate_xml | – month: 04 year: 2019 text: 2019-04-17 day: 17 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Journal of neuroinflammation |
PublicationTitleAlternate | J Neuroinflammation |
PublicationYear | 2019 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | 1469_CR31 A Tuttolomondo (1469_CR32) 2012; 58 1469_CR39 S Gupta (1469_CR3) 1997; 99 1469_CR36 1469_CR35 LL Lanier (1469_CR5) 2005; 23 A Tuttolomondo (1469_CR24) 2012; 18 G Liuzzo (1469_CR38) 1999; 100 G Licata (1469_CR26) 2006; 19 National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (1469_CR12) 2002; 106 M Campanella (1469_CR15) 2002; 33 A Pinto (1469_CR25) 2009; 116 B Redmon (1469_CR10) 2014 1469_CR43 O Mandelboim (1469_CR42) 1998; 95 LE Rohde (1469_CR46) 1999; 19 A D'Andrea (1469_CR18) 1998; 230 RL Sacco (1469_CR9) 2013; 44 S Kulkarni (1469_CR6) 2008; 20 1469_CR44 G Mancia (1469_CR11) 2013; 31 RG Baker (1469_CR2) 2011; 13 VZ Rocha (1469_CR1) 2009; 6 VH Perry (1469_CR45) 1997; 3 A D’Andrea (1469_CR19) 1996; 184 JH Yen (1469_CR40) 2001; 193 O Mandelboim (1469_CR41) 1996; 274 1469_CR51 H Nakajima (1469_CR16) 1995; 155 DS Korbel (1469_CR22) 2009; 182 CS Witt (1469_CR23) 1999; 68 G Liuzzo (1469_CR34) 2000; 101 S Kim (1469_CR47) 2008; 105 1469_CR50 CM Weyand (1469_CR37) 1998; 102 1469_CR14 M Nowik (1469_CR30) 2007; 58 A Maria De (1469_CR20) 1997; 94 HP Adams Jr (1469_CR13) 1993; 24 ZG Nadareishvili (1469_CR29) 2004; 63 SI Khakoo (1469_CR49) 2004; 305 A Tuttolomondo (1469_CR27) 2009; 2015 S Kim (1469_CR48) 2005; 436 GK Hansson (1469_CR4) 2011; 12 1469_CR28 SGE Marsh (1469_CR33) 2002 T Nakajima (1469_CR7) 2003; 93 L Battistini (1469_CR17) 1997; 159 M Uhrberg (1469_CR21) 1997; 7 D Bona Di (1469_CR8) 2014; 210 |
References_xml | – volume: 95 start-page: 3798 year: 1998 ident: 1469_CR42 publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.95.7.3798 – volume: 184 start-page: 789 year: 1996 ident: 1469_CR19 publication-title: J Exp Med doi: 10.1084/jem.184.2.789 – volume: 182 start-page: 6426 issue: 10 year: 2009 ident: 1469_CR22 publication-title: J Immunol doi: 10.4049/jimmunol.0804224 – volume: 274 start-page: 2097 year: 1996 ident: 1469_CR41 publication-title: Science doi: 10.1126/science.274.5295.2097 – volume: 2015 start-page: 84 issue: 1–2 year: 2009 ident: 1469_CR27 publication-title: J Neuroimmunol doi: 10.1016/j.jneuroim.2009.06.019 – volume: 230 start-page: 25 year: 1998 ident: 1469_CR18 publication-title: Curr Top Microbiol Immunol – volume: 19 start-page: 639 issue: 3 year: 2006 ident: 1469_CR26 publication-title: Int J Immunopathol Pharmacol doi: 10.1177/039463200601900320 – ident: 1469_CR36 doi: 10.1161/ATVBAHA.113.302163 – volume: 100 start-page: 2135 year: 1999 ident: 1469_CR38 publication-title: Circulation doi: 10.1161/01.CIR.100.21.2135 – volume: 24 start-page: 35 year: 1993 ident: 1469_CR13 publication-title: Stroke doi: 10.1161/01.STR.24.1.35 – volume: 101 start-page: 2883 year: 2000 ident: 1469_CR34 publication-title: Circulation doi: 10.1161/01.CIR.101.25.2883 – volume: 18 start-page: 4289 issue: 28 year: 2012 ident: 1469_CR24 publication-title: Curr Pharm Des doi: 10.2174/138161212802481200 – volume: 68 start-page: 1784 year: 1999 ident: 1469_CR23 publication-title: Transplantation doi: 10.1097/00007890-199912150-00024 – volume: 19 start-page: 1595 year: 1999 ident: 1469_CR46 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.19.7.1595 – volume: 44 start-page: 2064 issue: 7 year: 2013 ident: 1469_CR9 publication-title: Stroke doi: 10.1161/STR.0b013e318296aeca – volume: 63 start-page: 1446 year: 2004 ident: 1469_CR29 publication-title: Neurol doi: 10.1212/01.WNL.0000142260.61443.7C – ident: 1469_CR39 doi: 10.1016/j.jacc.2006.08.051 – volume: 105 start-page: 3053 issue: 8 year: 2008 ident: 1469_CR47 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0712229105 – volume: 305 start-page: 872 issue: 5685 year: 2004 ident: 1469_CR49 publication-title: Science doi: 10.1126/science.1097670 – volume-title: Killer-cell immunoglobulin-like receptors (KIR) nomenclature report year: 2002 ident: 1469_CR33 – volume: 13 start-page: 11 year: 2011 ident: 1469_CR2 publication-title: Cell Metab doi: 10.1016/j.cmet.2010.12.008 – volume: 58 start-page: 398 issue: 3 year: 2012 ident: 1469_CR32 publication-title: Cytokine doi: 10.1016/j.cyto.2012.02.012 – volume: 116 start-page: 781 issue: 10 year: 2009 ident: 1469_CR25 publication-title: Clin Sci doi: 10.1042/CS20080372 – volume: 31 start-page: 1281 issue: 7 year: 2013 ident: 1469_CR11 publication-title: J Hypertens doi: 10.1097/01.hjh.0000431740.32696.cc – ident: 1469_CR44 doi: 10.4049/jimmunol.1302843 – volume: 23 start-page: 225 year: 2005 ident: 1469_CR5 publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.23.021704.115526 – volume: 193 start-page: 1159 issue: 10 year: 2001 ident: 1469_CR40 publication-title: J Exp Med doi: 10.1084/jem.193.10.1159 – volume: 436 start-page: 709 year: 2005 ident: 1469_CR48 publication-title: Nature doi: 10.1038/nature03847 – volume: 99 start-page: 2752 year: 1997 ident: 1469_CR3 publication-title: J Clin Invest doi: 10.1172/JCI119465 – volume: 159 start-page: 3723 issue: 8 year: 1997 ident: 1469_CR17 publication-title: J Immunol doi: 10.4049/jimmunol.159.8.3723 – ident: 1469_CR28 doi: 10.1385/NMM:7:3:229 – ident: 1469_CR14 doi: 10.1016/j.ijcard.2010.06.005 – volume: 7 start-page: 753 year: 1997 ident: 1469_CR21 publication-title: Immunity doi: 10.1016/S1074-7613(00)80394-5 – volume: 58 start-page: 26 year: 2007 ident: 1469_CR30 publication-title: Eur Neurol doi: 10.1159/000102163 – volume: 210 start-page: 1083 issue: 7 year: 2014 ident: 1469_CR8 publication-title: J Infect Dis doi: 10.1093/infdis/jiu226 – volume: 33 start-page: 586 year: 2002 ident: 1469_CR15 publication-title: Stroke doi: 10.1161/hs0202.103399 – volume: 6 start-page: 399 year: 2009 ident: 1469_CR1 publication-title: Nat Rev Cardiol doi: 10.1038/nrcardio.2009.55 – ident: 1469_CR35 doi: 10.1016/j.coi.2005.03.006 – volume: 155 start-page: 4139 issue: 9 year: 1995 ident: 1469_CR16 publication-title: J Immunol doi: 10.4049/jimmunol.155.9.4139 – ident: 1469_CR31 doi: 10.1097/MD.0000000000000813 – ident: 1469_CR50 doi: 10.1016/j.cell.2010.08.031 – volume: 94 start-page: 10285 year: 1997 ident: 1469_CR20 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.94.19.10285 – volume: 20 start-page: 343 year: 2008 ident: 1469_CR6 publication-title: Semin Immunol doi: 10.1016/j.smim.2008.06.003 – ident: 1469_CR51 doi: 10.1002/eji.200425932 – volume-title: Diagnosis and management of type 2 diabetes mellitus in adults year: 2014 ident: 1469_CR10 – ident: 1469_CR43 doi: 10.1002/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6 – volume: 12 start-page: 204 year: 2011 ident: 1469_CR4 publication-title: Nat Immunol doi: 10.1038/ni.2001 – volume: 106 start-page: 3143 issue: 25 year: 2002 ident: 1469_CR12 publication-title: Circulation doi: 10.1161/circ.106.25.3143 – volume: 93 start-page: 106 issue: 2 year: 2003 ident: 1469_CR7 publication-title: Circ Res doi: 10.1161/01.RES.0000082333.58263.58 – volume: 102 start-page: 131 year: 1998 ident: 1469_CR37 publication-title: Mech Ageing Dev doi: 10.1016/S0047-6374(97)00161-9 – volume: 3 start-page: 337 year: 1997 ident: 1469_CR45 publication-title: Mol Med Today doi: 10.1016/S1357-4310(97)01077-0 |
SSID | ssj0032562 |
Score | 2.4556985 |
Snippet | In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA) class I... Introduction In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen (HLA)... Abstract Introduction In humans, a major component of natural killer (NK) and T cell target recognition depends on the surveillance of human leukocyte antigen... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 88 |
SubjectTerms | Aged Alleles Angina pectoris Antigens Arteriosclerosis Atherosclerosis Cardiovascular disease Cloning Cross-Sectional Studies Cytomegalovirus Development and progression Diagnosis Family medical history Female Gene frequency Genetic aspects Genetic Predisposition to Disease - genetics Genotype Genotyping Heart attacks Histocompatibility antigen HLA Histocompatibility Antigens Class I - genetics HLA HLA antigens Hospitals Humans Hypotheses Immunoglobulin-like receptors Immunoglobulins Inflammation Ischemia Killer cell immunoglobulin-like receptors Killer cells Killer immunoglobulin-like receptors (KIRs) Ligands Lymphocytes Lymphocytes T Male Middle Aged Natural killer cells Patients Physiological aspects Receptors, KIR - genetics Rheumatoid arthritis Stroke Stroke - genetics Stroke - immunology Target recognition |
SummonAdditionalLinks | – databaseName: ProQuest Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bi9QwFA66gvgi3q2uEkHwAmUzSZukTzKKy3hZH8SFeQttLlpmacdp58F_7zltpm4R9rVJStOTc_mSc74Q8tKLnLmMq9RbCQDFC5cWNmOp5bkAh6VKz7Ea-eybXJ1nn9f5Om64dTGt8mATB0PtWot75CcckErGdKH1u-3vFG-NwtPVeIXGdXIDqcswpUutJ8AlwJ3zeJK50PKkA9-mMOeiSME-FGk-80UDZf__hvmSZ5pnTV5yQ6d3yO0YP9LlKPC75Jpv7pGbZ_GE_D6pV1-XtGwc3QxFfhQ35mmNRSAtcn9g3nl6UW88BUvntwC46esvn753byiStfZ_sHqK1g2NdKsdxX1aWtp972kNQBhT6WnX79qNf0DOTz_--LBK43UKqYWwpk-DzhbBKR50aQtfaBFAGCHkzApX6lIWPmjmufPBM1E4QFrKV9rhYMYtYNmH5KhpG_-Y0EwK4SS8SeYAJ7ktg5LlAvzhonLOCZ0Qdvixxkaucbzy4sIMmENLM8rCgCwQfBQmT8jbach2JNq4qvN7lNbUETmyhwft7qeJKmdUVcBstA3M-SwLldZIT8chRspzX1mWkFcoa4OaDB9ny1iQAFNETiyzzDUaPAhwE3I86wkaaOfNh9ViogXozL_1mpAXUzOOxKy2xrf7sY-A-JGLhDwaF9c0JcGQCY5nCVGzZTeb87ylqX8N_OASAg6lF0-u_qyn5BZHVUDeSnVMjvrd3j-DAKuvng9a9BeOmyPg priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA_nCeKL-G31lAiCH1AvmzRN-iCyisf6sT6IC_cW2nxo2aU9t13w_ntn2m654uGTr02mNPORmWlmfiHkmReSuYSr2NsUEhQvXJzZhMWWSwEOS-WeYzfy8mu6WCWfTuXpAdlfbzUwsLk0tcP7pFbbzevfv87fgsG_6Qxep8cN-CyFtRRZDHafxfIKuQqOSaGdLpPxUEGAd-fDwealZBPX1CH4_71PX3BU0yLKC17p5Ca5MYSTdN7L_xY58NVtcm05HJjfIeXiy5zmlaPrrueP4n96WmJPSI1QIFiGHm_Ktaew8fkzyL_pi88fvzUvKWK3tufYTEXLig7oqw3F37Y0t7vW0xKYh5X1tGm39drfJauTD9_fL-LhdoXYQpTTxkEns-AUDzq3mc-0CCCbECSzwuU6TzMfNPPc-eCZyBwkXsoX2iEx4xZS23vksKor_4DQJBXCpfCmVEJ2yW0eVJrPwD3OCuec0BFhe8YaO0CP4w0YG9OlIDo1vSwMyAJzkczIiLwaSc563I1_TX6H0honImR296De_jCDBRpVZLAabQNzPklCoTWi1XEImaT0hWUReY6yNqhq8HE2H_oTYIkIkWXmUuP-B_FuRI4mM8Eg7XR4ry1mr8-GQ6KdMJ1pYMbTcRgpscit8vWunyMgnOQiIvd75RqXJBgCw_EkImqidpM1T0eq8mcHF55C_KH07OH_YNIjcp2jwSDYpToih-125x9DVNYWTzpb-wPHSjP3 priority: 102 providerName: Scholars Portal |
Title | HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30995924 https://www.proquest.com/docview/2211408988 https://www.proquest.com/docview/2211327323 https://pubmed.ncbi.nlm.nih.gov/PMC6471781 https://doaj.org/article/7b9e2d8cf0de44fb881367207555ebc0 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Ja9wwFBZtCqWX0r1u0kGFQhcwkSVr8XFSEqbLhBIamJuwtRAzwRMynkP_fd6zPcOYQnvpxQdLMtbT2z776RMh74OQzOdcp8EpAChB-LRwOUsdlwICli4Dx93I83M1u8y_LeRi76gvrAnr6YF7wR3rqgjcGxeZD3keK2OQZIxDpJMyVK5D6xDztmCq98ECAjkf_mFmRh2vIapprLYoUvAMRSpHUagj6__TJe_FpHG95F4AOntCHg-ZI532b_yU3AvNM_JwPvwbf07q2Y8pLRtPl932Poqf5GmN2z9WyPqBFefpdb0MFHxcuAGoTT9-_3qx_kSRprX9jfumaN3QgWh1TfELLS3dpg20BgiMRfR03d6uluEFuTw7_fVllg4HKaQOEpo2jSbPotc8mtIVoTAiwjLEKJkTvjSlKkI0DKQcYmCi8ICxdKiMx8GMO0CxL8lBs2rCa0JzJYRX8CQlAUhyV0atygwiYVZ574VJCNsK1rqBZRwPu7i2HdowyvZrYWEtEHYUVibk827ITU-x8bfOJ7hau47Ijt3dAJ2xg87Yf-lMQj7gWlu0YXg5Vw5bEWCKyIZlp9Kgq4PUNiFHo55ge27cvNUWO9j-2nLA1DkzhQFhvNs140isZ2vCatP3EZA5cpGQV71y7aYkGHLA8TwheqR2ozmPW5r6qmMGV5BqaJO9-R9COiSPOBoM8lrqI3LQ3m7CW0jA2mpC7uuFnpAHJ6fnPy8mneXBdZ6bO901L94 |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamTgJeEHcCA4wE4iJFc-xcnAeEOtjU0ovQtEl78xLbgahTUppUaH-K38g5TVIWIe1tr7Vd2Tl3-5zvEPLGioAZn0eu1SEEKFYYN9Y-czUPBBisKLEcq5Fn83B06n87C852yJ-uFgbTKjuduFHUptR4R77PIVLxmYyl_Lz85WLXKHxd7VpoNGwxsZe_IWSrPo2_An3fcn50ePJl5LZdBVwN1r12M-l7mYl4JhMd21iKDPaUZQHTwiQyCWObSWa5sZllIjYQcEQ2lQYXM649vAAFlb_rCwhlBmT34HD-_bjT_QIcCN6-nXoy3K_AmkaY5RG7oJFiN-hZv02TgP9NwRVb2M_TvGL4ju6Ru63HSocNi90nO7Z4QG7N2jf5hyQfTYc0KQxdbMoKKT4F0BzLTkpEG8FMd_ciX1gKutUuIcSn7yfj4-oDRXjY-hLrtWhe0BbgtaJ4M0wTva4tzSH0xuR9WtWrcmEfkdMb-dSPyaAoC_uUUD8UwoTwT2EAASzXSRaFiQcW2EuNMUI6hHUfVukW3RybbFyoTZQjQ9XQQgEtMNyJVeCQj9slywba47rJB0it7URE5d78UK5-qFbIVZTGcBqpM2as72eplAiIx8ErCwKbauaQd0hrhboDNqeTtgQCjogoXGoYSFSx4FI7ZK83E2Re94c7blGtzqnUPwlxyOvtMK7EPLrClutmjgCPlQuHPGmYa3skwRB7jvsOiXps1ztzf6TIf24QyUNwcSLpPbt-W6_I7dHJbKqm4_nkObnDUSwQNTPaI4N6tbYvwL2r05etTFFyftNi_BfI1mMt |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=HLA+and+killer+cell+immunoglobulin-like+receptor+%28KIRs%29+genotyping+in+patients+with+acute+ischemic+stroke&rft.jtitle=Journal+of+neuroinflammation&rft.au=Antonino+Tuttolomondo&rft.au=Domenico+Di+Raimondo&rft.au=Rosaria+Pecoraro&rft.au=Alessandra+Casuccio&rft.date=2019-04-17&rft.pub=BMC&rft.eissn=1742-2094&rft.volume=16&rft.issue=1&rft.spage=1&rft.epage=15&rft_id=info:doi/10.1186%2Fs12974-019-1469-5&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_7b9e2d8cf0de44fb881367207555ebc0 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-2094&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-2094&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-2094&client=summon |